The fact that UGT2B15 gene expression was markedly reduced in uterine and breast cancer cell lines expressing a mutant, compared to cell lines containing a wild-type, p53, indicates that expression and, probably, the action of UGT2B15 requires a functional p53 pathway. The gene discussed is TP53; the disease is breast cancer.